Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer ModelsSeiji Mabuchi, Yuji Murata, Masahide Ohmichi et al.|Journal of Biological Chemistry|2004Cited by 212
Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell LineJun Hayakawa, Yuji Murata, Dan Mercola et al.|Journal of Biological Chemistry|1999Cited by 174
Induction of hTERT expression and phosphorylation by estrogen via Akt cascade in human ovarian cancer cell linesAkiko Kimura, Yuji Murata, Masahide Ohmichi et al.|Oncogene|2004Cited by 146
Inhibition of Inhibitor of Nuclear Factor-κB Phosphorylation Increases the Efficacy of Paclitaxel in <b> <i>in Vitro</i> </b> and <b> <i>in Vivo</i> </b> Ovarian Cancer ModelsSeiji Mabuchi, Yuji Murata, Masahide Ohmichi et al.|Clinical Cancer Research|2004Cited by 114
Activation of the Luteinizing Hormone β Promoter by Gonadotropin-releasing Hormone Requires c-Jun NH2-terminal Protein KinaseTakeshi Yokoi, Yuji Murata, Masahide Ohmichi et al.|Journal of Biological Chemistry|2000Cited by 94